T. Rowe Price Health Care ETF (TMED)
NASDAQ: TMED · Real-Time Price · USD
34.83
-0.42 (-1.20%)
Jul 10, 2026, 4:00 PM EDT - Market closed
-1.20% (1D)
| Assets | $22.20M |
| Expense Ratio | 0.44% |
| PE Ratio | 28.03 |
| Shares Out | 700,000 |
| Dividend (ttm) | $0.16 |
| Dividend Yield | 0.46% |
| Ex-Dividend Date | Dec 23, 2025 |
| Payout Frequency | n/a |
| Payout Ratio | 12.85% |
| Volume | 5,617 |
| Open | 34.93 |
| Previous Close | 35.25 |
| Day's Range | 34.69 - 34.93 |
| 52-Week Low | 23.46 |
| 52-Week High | 35.68 |
| Beta | n/a |
| Holdings | 105 |
| Inception Date | Jun 11, 2025 |
About TMED
Fund Home PageThe T. Rowe Price Health Care ETF (TMED) is an exchange-traded fund. The ETF currently has 22.41m in AUM and 99 holdings. TMED is an actively managed ETF, aiming to outperform its respective sector index TMED was launched on Jun 11, 2025 and is issued by T. Rowe Price.
Top 10 Holdings
48.01% of assets| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly and Company | LLY | 16.39% |
| UnitedHealth Group Incorporated | UNH | 6.51% |
| Gilead Sciences, Inc. | GILD | 4.76% |
| Thermo Fisher Scientific Inc. | TMO | 4.08% |
| Cencora, Inc. | COR | 3.17% |
| Danaher Corporation | DHR | 2.89% |
| Alnylam Pharmaceuticals, Inc. | ALNY | 2.72% |
| Intuitive Surgical, Inc. | ISRG | 2.60% |
| Agilent Technologies, Inc. | A | 2.47% |
| Insulet Corporation | PODD | 2.40% |
Performance
TMED had a total return of 38.84% in the past year, including dividends. Since the fund's inception, the average annual return has been 36.72%.
News
When Eli Lilly Pivots, TMED's Strategy Wins
The T. Rowe Price Health Care ETF (TMED) led all T. Rowe Price funds last week, posting a 3.4% return.
6 weeks ago - ETF Trends
T. ROWE PRICE ADDS THREE NEW TRANSPARENT SECTOR OFFERINGS TO ITS ACTIVE ETF ROSTER
BALTIMORE, June 12, 2025 /PRNewswire/ -- T. Rowe Price (NASDAQ-GS: TROW), a global investment management firm, announced today the addition of three new active transparent equity exchange-traded funds...
1 year ago - PRNewsWire